Growth Metrics

Burning Rock Biotech (BNR) Asset Utilization Ratio: 2021-2024

Historic Asset Utilization Ratio for Burning Rock Biotech (BNR) over the last 4 years, with Dec 2024 value amounting to 0.53.

  • Burning Rock Biotech's Asset Utilization Ratio rose 17.57% to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year increase of 17.57%. This contributed to the annual value of 0.53 for FY2024, which is 31.31% up from last year.
  • As of FY2024, Burning Rock Biotech's Asset Utilization Ratio stood at 0.53, which was up 31.31% from 0.40 recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Asset Utilization Ratio ranged from a high of 0.53 in FY2024 and a low of 0.21 during FY2021.
  • Over the past 3 years, Burning Rock Biotech's median Asset Utilization Ratio value was 0.40 (recorded in 2023), while the average stood at 0.40.
  • In the last 5 years, Burning Rock Biotech's Asset Utilization Ratio skyrocketed by 44.64% in 2023 and then crashed by 31.31% in 2024.
  • Burning Rock Biotech's Asset Utilization Ratio (MRY) stood at 0.21 in 2021, then soared by 33.50% to 0.28 in 2022, then surged by 44.64% to 0.40 in 2023, then surged by 31.31% to 0.53 in 2024.
  • Its last three reported values are 0.53 in FY2024, 0.40 for FY2023, and 0.28 during FY2022.